Biocraft
Executive Summary
Recalls selected batches of disopyramide phosphate, SMXrI'MP tablets, cephalexin oral powder, amoxicillin chewable tablets and halts production of liquid amoxicillin for humans and animals, liquid ampicillin, amiloride and liquid nystatin as part of consent decree reached with the Justice Department July 28. Biocraft announced July 21 that it was halting shipments of nystatin oral suspension and amoxicillin powder for oral suspension and as part the pending consent decree ("The Pink Sheet" July 25, T&G-1)